Lisdexamfetamine Dimesylate for Adults with Moderate to Severe Binge Eating Disorder: Results of Two Pivotal Phase 3 Randomized Controlled Trials.
about
Novel pharmacologic treatment in acute binge eating disorder - role of lisdexamfetamineLisdexamfetamine in the treatment of moderate-to-severe binge eating disorder in adults: systematic review and exploratory meta-analysis of publicly available placebo-controlled, randomized clinical trialsA Phase 3, Multicenter, Open-Label, 12-Month Extension Safety and Tolerability Trial of Lisdexamfetamine Dimesylate in Adults With Binge Eating DisorderBinge-Eating Disorder in Adults: A Systematic Review and Meta-analysis.Symptoms of Attention Deficit Hyperactivity Disorder (ADHD) among adult eating disorder patients.Aggressive clinical approach to obesity improves metabolic and clinical outcomes and can prevent bariatric surgery: a single center experienceThe Cost Effectiveness of Lisdexamfetamine Dimesylate for the Treatment of Binge Eating Disorder in the USA.Recognizing Binge-Eating Disorder in the Clinical Setting: A Review of the Literature.Efficacy of Lisdexamfetamine in Adults With Moderate to Severe Binge-Eating Disorder: A Randomized Clinical Trial.Dopamine and μ-opioid receptor dysregulation in the brains of binge-eating female rats - possible relevance in the psychopathology and treatment of binge-eating disorder.Investigation of impulsivity in binge-eating rats in a delay-discounting task and its prevention by the d-amphetamine prodrug, lisdexamfetamine.The Prevalence of Past 12-Month and Lifetime DSM-IV Eating Disorders by BMI Category in US Men and Women.Lisdexamfetamine reduces the compulsive and perseverative behaviour of binge-eating rats in a novel food reward/punished responding conflict model.Time course of the effects of lisdexamfetamine dimesylate in two phase 3, randomized, double-blind, placebo-controlled trials in adults with binge-eating disorderA randomized, double-blind, placebo-controlled, dose-ranging study of lisdexamfetamine dimesylate augmentation for major depressive disorder in adults with inadequate response to antidepressant therapy.Concurrent Improvement in Both Binge Eating and Depressive Symptoms with Naltrexone/Bupropion Therapy in Overweight or Obese Subjects with Major Depressive Disorder in an Open-Label, Uncontrolled Study.Safety of pharmacotherapy options for bulimia nervosa and binge eating disorder.Lisdexamfetamine dimesylate in binge eating disorder: a placebo controlled trial.Lisdexamfetamine: chemistry, pharmacodynamics, pharmacokinetics, and clinical efficacy, safety, and tolerability in the treatment of binge eating disorder.Lisdexamfetamine: A Review in Binge Eating Disorder.Psychopharmacological advances in eating disorders.Phenotypes of Obesity: How it Impacts Management.Relationships between clinical scales and binge eating days in adults with moderate to severe binge eating disorder in two Phase III studies.Psychological, pharmacological, and combined treatments for binge eating disorder: a systematic review and meta-analysis.Machine Learning Based Classification of Deep Brain Stimulation Outcomes in a Rat Model of Binge Eating Using Ventral Striatal Oscillations
P2860
Q26752974-BF327BE1-72F9-440B-AB64-F4DE38F6EF33Q28553322-503563C7-D2C8-47F9-B656-E41078CA948AQ33590913-0AE02DDD-90AA-4728-A6BB-D535FCB47A2AQ36065939-1794A34E-96A3-4830-9EDA-926DF4DDE958Q36251933-47BE26ED-1A18-4BA2-8194-2C32DA305C8DQ36291168-17482B4E-3560-43E2-BBEC-2E801572CC67Q36712713-C4D391AE-832B-4185-A406-B853980DE9ACQ37281318-68E8C00C-F043-407A-90C3-211C1FE07085Q38374118-F1060769-E63B-4BAB-80B7-D2F3AF373F3FQ38855288-A09C7CCB-00C1-4935-9560-76BBF44DCBECQ38858169-2279F58F-8FCF-4606-823B-803D2933258AQ38996050-355A5C6B-9225-4C9F-97F4-C185C8D09FEAQ39773112-3C45554B-2617-4B9B-BBB5-15B535B8E8F0Q41539924-1A5A2491-3F70-4CC6-82FB-CE87409D851DQ42361284-99E67535-8FC4-44D3-A2EF-76CBA995E801Q43126342-33B292E3-3694-4B80-91D7-FDA31E13EFF8Q47289729-E2535789-0AA8-4165-BEDB-A76FF1BE8DAAQ47605378-446F78C8-03E1-4496-83F6-F1CB09C8B818Q47652489-9B3121B3-CA91-4FDC-AEF0-10B67E489DFEQ47663515-EE01A546-1F35-4896-9D16-0FA0B985F0F4Q48103049-E79C0D25-1FFE-4F53-B39A-4A1E71C75E98Q49834355-561223A8-D486-4360-8DC1-FFFB841DBBBAQ51745513-56D58F2C-E02D-4C6D-8672-84ACD267E19AQ55500360-33B8BD7B-5572-4D4F-B17D-144262EEB0DDQ58801906-F59E6CE7-2751-4ACA-96B7-9A2BA807DF7C
P2860
Lisdexamfetamine Dimesylate for Adults with Moderate to Severe Binge Eating Disorder: Results of Two Pivotal Phase 3 Randomized Controlled Trials.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Lisdexamfetamine Dimesylate fo ...... Randomized Controlled Trials.
@ast
Lisdexamfetamine Dimesylate fo ...... Randomized Controlled Trials.
@en
type
label
Lisdexamfetamine Dimesylate fo ...... Randomized Controlled Trials.
@ast
Lisdexamfetamine Dimesylate fo ...... Randomized Controlled Trials.
@en
prefLabel
Lisdexamfetamine Dimesylate fo ...... Randomized Controlled Trials.
@ast
Lisdexamfetamine Dimesylate fo ...... Randomized Controlled Trials.
@en
P2093
P2860
P356
P1476
Lisdexamfetamine Dimesylate fo ...... Randomized Controlled Trials.
@en
P2093
James Hudson
Jana Radewonuk
M Celeste Ferreira-Cornwell
Maria Gasior
Susan L McElroy
Timothy Whitaker
P2860
P2888
P304
P356
10.1038/NPP.2015.275
P407
P577
2015-09-07T00:00:00Z